The FAA currently prohibits pilots from using ADHD medications, citing safety concerns. Despite expanding antidrepressant approvals, it has never approved ADHD treatments. A bipartisan Senate bill could mandate a reevaluation of this policy to encourage rather than punish treatment disclosure, addressing the growing pilot shortage and improving safety regulations.

